Abiopharma

🔍 Colgrove John (Director)

Company: Everpure, Inc. (P)

Report Date: 2026-08-13

Detailed Transactions and Holdings:

• Sold 100,000 shares of Class A Common Stock (Direct)
  Date: 2026-08-13 | Code: G | equity_swap_involved: 0 | shares_owned_after: 6,074,080.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 100,000 shares of Class A Common Stock (Direct)
  Date: 2026-08-13 | Code: G | equity_swap_involved: 0 | shares_owned_after: 100,000.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 900 shares of Class A Common Stock at $112.56 per share (Direct)
  Date: 2026-08-13 | Code: S | equity_swap_involved: 0 | shares_owned_after: 99,100.00 | transaction_form_type: 4 | Footnotes: F3, F4, F2
• Sold 1,200 shares of Class A Common Stock at $113.88 per share (Direct)
  Date: 2026-08-13 | Code: S | equity_swap_involved: 0 | shares_owned_after: 97,900.00 | transaction_form_type: 4 | Footnotes: F3, F5, F2
• Sold 2,872 shares of Class A Common Stock at $115.16 per share (Direct)
  Date: 2026-08-13 | Code: S | equity_swap_involved: 0 | shares_owned_after: 95,028.00 | transaction_form_type: 4 | Footnotes: F3, F6, F2
• Sold 9,454 shares of Class A Common Stock at $116.27 per share (Direct)
  Date: 2026-08-13 | Code: S | equity_swap_involved: 0 | shares_owned_after: 85,574.00 | transaction_form_type: 4 | Footnotes: F3, F7, F2
• Sold 45,906 shares of Class A Common Stock at $117.13 per share (Direct)
  Date: 2026-08-13 | Code: S | equity_swap_involved: 0 | shares_owned_after: 39,668.00 | transaction_form_type: 4 | Footnotes: F3, F8, F2
• Sold 39,668 shares of Class A Common Stock at $117.87 per share (Direct)
  Date: 2026-08-13 | Code: S | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F3, F9, F2
• Sold 64,815 shares of Class A Common Stock (Direct)
  Date: 2026-08-14 | Code: G | equity_swap_involved: 0 | shares_owned_after: 6,009,265.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 64,815 shares of Class A Common Stock (Direct)
  Date: 2026-08-14 | Code: G | equity_swap_involved: 0 | shares_owned_after: 64,815.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Sold 4,400 shares of Class A Common Stock at $115.86 per share (Direct)
  Date: 2026-08-14 | Code: S | equity_swap_involved: 0 | shares_owned_after: 60,415.00 | transaction_form_type: 4 | Footnotes: F3, F10, F2
• Sold 18,924 shares of Class A Common Stock at $116.74 per share (Direct)
  Date: 2026-08-14 | Code: S | equity_swap_involved: 0 | shares_owned_after: 41,491.00 | transaction_form_type: 4 | Footnotes: F3, F11, F2
• Sold 34,178 shares of Class A Common Stock at $117.83 per share (Direct)
  Date: 2026-08-14 | Code: S | equity_swap_involved: 0 | shares_owned_after: 7,313.00 | transaction_form_type: 4 | Footnotes: F3, F12, F2
• Sold 7,313 shares of Class A Common Stock at $118.4 per share (Direct)
  Date: 2026-08-14 | Code: S | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F3, F13, F2
• Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-08-13 | Code: H | nature_of_ownership: By Trust | shares_owned_after: 467,694.00 | Footnotes: F14
• Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-08-13 | Code: H | nature_of_ownership: By Trust | shares_owned_after: 2,515,000.00 | Footnotes: F15
• Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-08-13 | Code: H | nature_of_ownership: By Trust | shares_owned_after: 2,515,000.00 | Footnotes: F16

Footnotes:

• F1: The reported gift was made to The Colgrove Family Charitable Remainder Trust.
• F2: Shares are held by The Colgrove Family Charitable Remainder Trust.
• F3: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on behalf of the applicable trust on January 8, 2026.
• F4: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $112.44 to $113.19 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
• F5: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $113.49 to $114.30 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
• F6: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $114.61 to $115.59 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
• F7: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $115.61 to $116.60 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
• F8: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $116.61 to $117.60 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
• F9: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $117.61 to $118.60 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
• F10: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $115.24 to $116.23 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
• F11: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $116.25 to $117.24 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
• F12: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $117.26 to $118.24 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
• F13: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $118.26 to $118.60 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
• F14: Shares are held by Colgrove Family Living Trust.
• F15: Shares are held by The EEC Irrevocable Trust. A member of the Reporting Person's immediate family is a beneficiary of the trust.
• F16: Shares are held by The RWC Irrevocable Trust. A member of the Reporting Person's immediate family is a beneficiary of the trust.